Athenex logo

Athenex ATNX

$ 0.2 -23.39%

Annual report 2022
added 03-20-2023

report update icon

Country

usaUSA

IPO year

2017

Industry

Drug manufacturers

Stock Exchange

NASDAQ GLOBAL

CEO

Dr. Johnson Lau

Employees in the company

574

Shares

6.54 M

Market Cap[1]

$ 1.76 M

EBITDA (LTM)

$ -101 M

P/E (LTM)

-2.62

P/S (LTM)

0.17

EPS (LTM)

-0.96

Other stocks of industry "Drug manufacturers"

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.